Drug intelligence / Profile preview

Onecet ER

Development stage
Unknown
Lead developer
Daewon Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Onecet ER is a fixed-dose combination of tramadol hydrochloride and acetaminophen in a sustained-release (SR) formulation, developed by Daewon Pharmaceutical. Tramadol is a centrally acting synthetic opioid analgesic that exerts its effect through mu-opioid receptor agonism and the inhibition of norepinephrine and serotonin reuptake. Acetaminophen is a non-opioid analgesic and antipyretic that primarily inhibits prostaglandin synthesis in the central nervous system. This combination provides synergistic analgesic effects for the management of moderate to severe pain, such as chronic low back pain. The SR formulation is designed to provide prolonged pain relief with a reduced dosing frequency (typically twice daily) compared to immediate-release formulations, potentially improving patient compliance and maintaining stable plasma concentrations.

Brand names
Onecet EROnecet SR
Other names
Tramadol hydrochloride + Acetaminophen SRTramadol/Acetaminophen SR Daewon원셋서방정
02

Targets

NET (Norepinephrine Transporter)MOR (Mu opioid receptor)SERT (Sodium-dependent serotonin transporter)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on Onecet ER.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onecet ER.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call